Results per Page:
ReLiC: A genetic screening method to study RNA regulation
From the Subramaniam Lab, Basic Sciences Division
Looking beyond suspect genes in cancer
Fred Hutch is among 10 institutions in the U.S., the U.K. and Europe collaborating to find the function of every protein-coding gene in the human genome
‘Manufacturing scientist’ believes in the machinery that powers Fred Hutch’s cell therapies
Dr. Folashade Otegbeye is the recipient of the Fleischauer Family Endowed Chair in Cell and Gene Therapy Translation
Fred Hutch study finds genetic driver of drug resistance in small cell lung cancer
Researchers use CRISPR-Cas9 gene-editing tool on tumor cells grown in mice to better model how tumors that initially respond to chemotherapy become resistant
Now you see them, now you don’t: Gene editing protects stem cells from CAR T therapy
From the Kiem lab, Translational Science and Therapeutics Division
Uncovering a player responsible for boosting RIT1 protein abundance and cancer promoting activity
From the Berger Lab, Human Biology Division
Jennifer Doudna: ‘Curiosity-driven, fundamental science’ underpins Nobel Prize-winning work
CRISPR pioneer spoke at inaugural Fred Hutch President’s Seminar, outlined goals for gene-editing technology
Finding the golden ticket? Cyclin T1 is required for HIV-1 latency reactivation
From the Emerman lab, Human Biology and Basic Sciences Divisions
From the bench to Hutch services: Refining gene-editing methods for HSPCs used in pre-clinical applications
From the Paddison lab, Human Biology Division
Hitting ‘undo’ to cure Sickle Cell Disease
From the Lieber and Kiem Labs, Hematologic Malignancies Program, Cancer Consortium.
Panning for gold in a dependent-sea of genes
From the Emerman Lab, Human Biology and Basic Sciences Divisions
Uncovering cancer growth genes that have each other’s back when the other is down
From the Berger Lab, Human Biology Division
Searching beyond the streetlight to uncover functional protein domains
From the Paddison Lab, Human Biology Division
Could gene twins team up against cancer?
New approach uncovers gene duplications that could be targets for cancer drugs
TOP delivery of CRISPR-Cas9 machinery to primary T cells
From the Overbaugh Lab, Human Biology Division
Advances in blood disorders research continue despite COVID-19
Expanding use of CAR T-cell therapies, gene editing lead to insights at virtual annual meeting of the American Society of Hematology
Improved CRISPR-Cas9 delivery method allows for fast and precise knockouts
From the Paddison lab, Human Biology Division
¿La cura del herpes? Hay avances que reportar
Los estudios con ratones muestran que la terapia génica puede reducir muchísimo las infecciones inactivas
Discovering new strategies used in arms race between bacteria and the viruses that infect them
Dr. Kevin Forsberg tapped for NIAID New Innovators Award to study arms race between viruses and bacteria
Your vote needed! Hutch science competes in 'STAT Madness'
Studies by Drs. Justin Taylor, Robert Bradley are finalists in annual competition for best biomedical advance